NASDAQ: YDES
Yd Bio Ltd Earnings Dates, Reports, Calls

Yd Bio earnings were -$8.3M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest YDES earnings report on Dec 31, 2025 announced Q4 2025 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, YDES reported annual earnings of -$8.3M, with 488.8% growth.

YDES earnings history

Current Revenue
$596.8k
Current Earnings
-$8.3M
Current Profit Margin
-1,392.6%

YDES Return on Equity

Current Company
-445.1%
Current Industry
-31.4%
Current Market
28.9%

YDES Return on Assets

Current Company
-80.5%
Current Industry
-9.6%
YDES is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when YDES announces earnings.

YDES Return on Capital Employed

Current Company
-68.5%
Current Industry
-3.7%
YDES's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

YDES vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
YDES-$8.10M-$8.31MN/A-$0.12
AVXL-$39.93M-$39.95MN/A-$0.46
FULC-$74.74M-$76.12MN/A-$1.15
HUMA-$79.74M-$97.59MN/A-$0.59
ACIUN/A-$84.90MN/A-$0.85

Yd Bio Earnings Reports & History FAQ

What were Yd Bio's earnings last quarter?

Yd Bio (NASDAQ: YDES) reported Q4 2025 earnings per share (EPS) of N/A, up N/A year over year. Total YDES earnings for the quarter were N/A. In the same quarter last year, Yd Bio's earnings per share (EPS) was $0.63.

If you're new to stock investing, here's how to buy Yd Bio stock.

Is Yd Bio profitable or losing money?

As of the last Yd Bio earnings report, Yd Bio is currently losing money. Yd Bio's net profit (also called net income) for the twelve months ending Dec 31, 2025 was -$8.31 million, a 488.8% increase year over year.

What was YDES's earnings growth in the past year?

As of Yd Bio's earnings date in Q2 2026, Yd Bio's earnings has grown year over year. YDES earnings in the past year totalled -$8.31 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.